Non-antigenic and antigenic interventions in type 1 diabetes
Type 1 diabetes (T1D) results from autoimmune destruction of the pancreatic β-cells. Current T1D therapies are exclusively focused on regulating glycemia rather than the underlying immune response. A handful of trials have sought to alter the clinical course of T1D using various broad immune-suppres...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Taylor & Francis
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896560/ |